Genome-wide analysis of HOXC9-induced neuronal differentiation of neuroblastoma cells

[1]  Shuang Huang,et al.  HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation , 2013, BMC Genomics.

[2]  B. McCarthy,et al.  HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma. , 2011, Cancer research.

[3]  S. Cohn,et al.  Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  H. Ding,et al.  Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner* , 2006, Journal of Biological Chemistry.

[5]  Richard A Young,et al.  Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.

[6]  K. Matthay,et al.  Retinoid therapy of high-risk neuroblastoma. , 2003, Cancer letters.

[7]  C J Gomer,et al.  Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. , 2001, Cancer research.

[8]  J. Lunec,et al.  Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. , 2001, Cancer research.

[9]  R. Ross,et al.  Human neuroblastoma I-type cells are malignant neural crest stem cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  H. Hosoi,et al.  Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. , 1988, Cancer research.

[11]  N. Sidell,et al.  Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. , 1982, Journal of the National Cancer Institute.